Avanzanite raised €32M in a Series A round of funding with MVM Partners.
01 November 2025
01 November 2025
Total investments received (USD): 37.28M
Round value (USD): 37.28M
Round investors: MVM Life Science Partners
Company: Avanzanite
Industry: BiotechHealth services
Related deals
Leyden Labs in a equity investment of €30M from the EIC - European Innovation Council Fund and Invest-NL
Investments
03 September 2025
Austria
Germany
Switzerland
Denmark
Estonia
Finland
Iceland
Latvia
Lithuania
Norway
Sweden
France
Ireland
Italy
Portugal
Spain